This phase II trial studies how well contrast-enhanced ultrasound (CEUS) works for diagnosing patients with renal cell cancer (RCC) that has come back (recurre…

Recurrent Renal Cell CarcinomaRenal Cell Carcinoma

~Estimated

~$10 – $7,500

john eisenbreyNCT05641935

Phase 2

A Phase 2 Study of RP2 With Tivozanib in Patients With Metastatic Renal Carcinoma After Progression to Immunotherapy

This phase II trial tests the effect of RP2 and tivozanib in treating patients with renal cell cancer that has spread from where it first started (primary site…

Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+6 more

~Estimated

~$10 – $6,250

City of Hope Medical CenterNCT07218692